Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Dec 21, 2012

30016_dirs_2012-12-21_ae93d88e-675d-4cf5-a176-5680765d5bc0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-12-20

Reporting Person: BROWN WILLIAM E III (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-20 Common Stock M 4087 $29.36 Acquired 7259 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-20 Incentive Stock Option (right to buy) $29.36 M 4087 Disposed 2015-12-02 Common Stock (4087) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 3,405 shares on 12/03/2009, 12/03/2010, 12/03/2011, 12/03/2012, and 12/03/2013.